Skip to main content
. 2020 Feb 21;37(4):271–279. doi: 10.1007/s40266-020-00753-2

Fig. 3.

Fig. 3

Incidence of abdominal pain (a), diarrhea (b), nausea (c), and vomiting (d) by age at baseline (COMPOSE-1, COMPOSE-2, and COMPOSE-3 safety population). NAL naldemedine